Micro Systemation (OM:MSAB B) Stock Faces Lumpy Quarters Despite 129.1% Earnings Growth Narrative

Simply Wall St

Micro Systemation (OM:MSAB B) has reported a clean set of Q2 2026 numbers, with revenue of 122.5 million SEK and basic EPS of 0.51 SEK. Trailing twelve month EPS stands at 3.79 SEK, reflecting the 129.1% earnings growth cited over the last year. The company’s revenue increased from 80.5 million SEK in Q2 2025 to 122.5 million SEK in Q2 2026, while quarterly basic EPS moved from a loss of 0.78 SEK to a profit of 0.51 SEK, setting the backdrop for the current release. With net profit margin now higher than a year ago and the latest quarter contributing to that trend, investors may focus on how durable these margins appear as they evaluate the next step in the investment thesis.

See our full analysis for Micro Systemation.

With the headline results in place, the next step is to set these numbers against the most widely held narratives around Micro Systemation to see which views are supported by the data and which ones are brought into question.

Curious how numbers become stories that shape markets? Explore Community Narratives

OM:MSAB B Revenue & Expenses Breakdown as at Jul 2026

129.1% earnings growth meets lumpy quarters

  • Over the last 12 months, Micro Systemation’s earnings grew 129.1% with trailing net income of 70.072 million SEK and total revenue of 510.884 million SEK, even though individual quarters ranged from a loss of 5.8 million SEK in Q1 2026 to a profit of 35.1 million SEK in Q3 2025.
  • What stands out for a bullish view is that strong trailing growth and a 13.7% net profit margin sit alongside choppy quarterly figures. Investors who like the growth story need to be comfortable with periods such as Q1 2026, when revenue was 101.2 million SEK and the company reported a loss of 5.8 million SEK, and Q2 2025, when revenue was 80.5 million SEK and the company reported a loss of 14.4 million SEK.

Profitability steadies at 13.7% margin

  • On a trailing 12 month basis, Micro Systemation’s net profit margin is 13.7%, compared with 7.5% in the prior year, with trailing net income of 70.072 million SEK earned on 510.884 million SEK of revenue.
  • Supporters of a bullish narrative point to this margin profile as evidence that the business can turn revenue into profit, and the data backs that up over the last year. Quarterly swings remain, as seen in the move from a loss of 5.8 million SEK in Q1 2026 to a profit of 9.4 million SEK in Q2 2026, and from a loss of 14.4 million SEK in Q2 2025 to profits above 30 million SEK in Q3 and Q4 2025.
To see how the recent margin improvement fits into the longer term story that investors are debating around Micro Systemation, have a look at the 📊 Read the what the Community is saying about Micro Systemation..

P/E of 22.1x and DCF fair value gap

  • Micro Systemation trades on a trailing P/E of 22.1x, below the peer average of 88.4x and slightly below the Swedish Software industry average of 24.2x. The DCF fair value of 172.11 SEK per share sits well above the current share price of 84.0 SEK.
  • What many bullish investors focus on is that combination of a P/E that is lower than peers and a DCF fair value that is materially above the market price, set against trailing earnings per share of 3.793686 SEK and trailing net income of 70.072 million SEK. More cautious income focused investors may give weight to the unstable dividend record highlighted in the risk summary when weighing that apparent valuation gap.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Micro Systemation's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of optimism and caution around Micro Systemation resonates, consider taking prompt action to test the story against the numbers yourself and see what stands out, then weigh the 3 key rewards and 1 important warning sign

See What Else Is Out There

While Micro Systemation has strong trailing earnings and a 13.7% margin, the lumpy quarters and past losses highlight that results have not been consistently smooth.

If that patchy pattern makes you want steadier opportunities, it is worth checking stocks in the 288 resilient stocks with low risk scores that score better on consistency and overall risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Micro Systemation might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com